Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 6, 2026

Mar. 6, 2026

Catheter Precision’s LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026

GlobeNewswire

Mar. 6, 2026

Artelo Biosciences Announces Reverse Stock Split

GlobeNewswire

Mar. 6, 2026

Prenetics Authorizes $40 Million Share Repurchase Program

GlobeNewswire

Mar. 6, 2026

Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 6, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 6, 2026

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire

Mar. 6, 2026

Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 6, 2026

Verano to Report Fourth Quarter and 2025 Full Year Financial Results on March 12th, 2026

GlobeNewswire

Mar. 6, 2026

AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update

GlobeNewswire

Mar. 6, 2026

Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook

GlobeNewswire

Mar. 6, 2026

Tangram Therapeutics gibt Dosierung des ersten Studienteilnehmers in der Phase-I/II-Studie RESTORE-MASH zu TGM-312 bekannt, einem in der Entwicklungsphase befindlichen RNAi-Therapeutikum

GlobeNewswire

Mar. 6, 2026

Tangram Therapeutics annonce l’administration de la première dose à un participant dans le cadre de l’essai RESTORE-MASH de phase I/II portant sur le TGM-312, un nouveau médicament expérimental à base d’ARNi

GlobeNewswire

Mar. 6, 2026

Intended Retirement of Independent Non-executive Director and changes of composition of board committees

GlobeNewswire

Mar. 6, 2026

Claritas iPET™ Approved by Australia TGA to Supply the Medical Software Device for Image Processing Enabling Diagnostic Quality Images from Short Scan Time and/or Low Dose PET, PET-CT/MRI Scans

GlobeNewswire

Mar. 6, 2026

argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline

GlobeNewswire

Mar. 6, 2026

Paingone Plus TENS Pen Featured in 2026 Consumer Report Examining FDA Clearance Status, TENS Pain Therapy Research, and Portable Pain Relief Device Verification

GlobeNewswire

Mar. 6, 2026

Quipt Home Medical Receives Final Order Approving Arrangement

GlobeNewswire

Mar. 6, 2026

Rakovina Announces Closing of $1 Million Debenture Unit Private Placement and Debt Settlement Agreements

GlobeNewswire